| 000 | 01403 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515035853.0 | ||
| 264 | 0 | _c20070222 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a0014-2972 | ||
| 024 | 7 |
_a10.1111/j.1365-2362.2006.01683.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBonderman, D | |
| 245 | 0 | 0 |
_aBosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical investigation _cSep 2006 |
||
| 300 |
_a71-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBosentan |
| 650 | 0 | 4 | _aEndothelin Receptor Antagonists |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 |
_aTelangiectasia, Hereditary Hemorrhagic _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aNowotny, R | |
| 700 | 1 | _aSkoro-Sajer, N | |
| 700 | 1 | _aAdlbrecht, C | |
| 700 | 1 | _aLang, I M | |
| 773 | 0 |
_tEuropean journal of clinical investigation _gvol. 36 Suppl 3 _gp. 71-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2362.2006.01683.x _zAvailable from publisher's website |
| 999 |
_c16505549 _d16505549 |
||